BlackRock »

Inozyme Pharma shares owned by BlackRock

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $18M 3.5M 5.23

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Inozyme Pharma

Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Eventide Asset Management
Rock Springs Capital Management
BlackRock
BlackRock
Samlyn Capital
Affinity Asset Advisors
Vanguard Group
NEA Management Company
Samsara BioCapital
Sphera Funds Management
Geode Capital Management
Saturn V Capital Management
Blue Owl Capital Holdings

View all funds holding Inozyme Pharma